Hans O. Kalkman
Novartis Pharma AG
Research Nervous System
Building WSJ-360-405
CH-4002 Basel
Switzerland
Name/email consistency: high
- alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs. Kalkman, H.O., Loetscher, E. Eur. J. Pharmacol. (2003)
- GAD(67): the link between the GABA-deficit hypothesis and the dopaminergic- and glutamatergic theories of psychosis. Kalkman, H.O., Loetscher, E. J. Neural. Transm (2003)
- Functional characterization of the novel antipsychotic iloperidone at human D2, D3, alpha 2C, 5-HT6, and 5-HT1A receptors. Kalkman, H.O., Feuerbach, D., Lötscher, E., Schoeffter, P. Life Sci. (2003)
- Antischizophrenic activity independent of dopamine D2 blockade. Kalkman, H.O. Expert Opin. Ther. Targets (2002)
- Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders. Kalkman, H.O., Subramanian, N., Hoyer, D. Neuropsychopharmacology (2001)